HighVista Strategies »

MasTec shares owned by HighVista Strategies

Quarter-by-quarter ownership of MasTec (MTZ) shares owned by HighVista Strategies from 13F filings

Historical chart of HighVista Strategies investment in MasTec

Tip: Access up to 7 years of quarterly data

All positions including MasTec held by HighVista Strategies consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in MasTec by HighVista Strategies

Quarter filed Position value Share count Share price at filing
2025-09-30 $1.4M 6.7k 212.81
2025-06-30 $1.9M 11k 170.43
2025-03-31 $1.9M 16k 116.71

More positions owned by HighVista Strategies

Invesco Db Commdy Indx Trck Unit (DBC)
Abivax Sa Sponsored Ads (ABVX)
Merus N V (MRUS)
Miragen Therapeutics (VRDN)
Revolution Medicines (RVMD)
Protagonist Therapeutics (PTGX)
Nuvalent Inc-a (NUVL)
Mineralys Therapeutics (MLYS)
Arcellx Common Stock (ACLX)
Agios Pharmaceuticals (AGIO)
Cytokinetics Com New (CYTK)
Insmed Com Par $.01 (INSM)
Cidara Therapeutics Com New (CDTX)
Cogent Biosciences (COGT)
Structure Therapeutics Sponsored Ads (GPCR)

View all positions for HighVista Strategies

Top funds holding MasTec

BlackRock
Vanguard Group
Hill City Capital
State Street Corporation
Invesco
Hood River Capital Management
Nordea Investment Management Ab
Geode Capital Management
First Trust Advisors
Victory Capital Management
Dimensional Fund Advisors
AQR Capital Management
Merewether Investment Management
Millennium Management
Electron Capital Partners

View all funds holding MasTec